Want to see HK:1931 full AI Analyst Report?
1931 Stock Chart & Stats
HK$3.85
HK$0.05(2.67%)
At close: 4:00 PM EST
HK$3.85
HK$0.05(2.67%)
Day’s Range― - ―
52-Week RangeHK$0.40 - HK$10.25
Previous CloseN/A
Volume18.00K
Average Volume (3M)222.93K
Market Cap
HK$664.81M
Enterprise ValueHK$11.51B
Total Cash (Recent Filing)HK$1.10B
Total Debt (Recent Filing)HK$2.60B
Price to Earnings (P/E)―
Beta0.78
Next Earnings
Mar 12, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield17.1%
Share Statistics
EPS (TTM)-0.05
Shares Outstanding1,621,488,000
10 Day Avg. Volume159,900
30 Day Avg. Volume222,933
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.29
Price to Sales (P/S)1.35
P/FCF Ratio-3.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Meaningful Equity BaseA sizable equity base provides some structural support while the company works through weaker earnings and cash generation. It can help absorb operational volatility and preserve strategic flexibility, although the benefit is reduced by higher leverage and sharply lower returns.
Prior Operating Track RecordThe company demonstrated a multi-year period of healthy margins and positive growth before the 2025 reset. That history indicates the business has previously converted revenue into operating profit effectively, creating a potential foundation for recovery if recent pressures moderate.
IVD Healthcare ExposureExposure to in-vitro diagnostics and healthcare places the company in a sector tied to medical testing and health services. This provides a durable business context beyond discretionary industries, though the pack does not establish a specific competitive advantage or growth rate.
Bears Say
Revenue And Margin CompressionThe simultaneous decline in revenue and operating profitability signals a material weakening in the earnings engine. Margin compression reduces the company’s ability to fund investment, withstand further pressure, and convert any eventual sales recovery into stronger shareholder returns.
Severe Cash BurnThe sharp reversal to deeply negative operating and free cash flow is a significant fundamental weakness. Persistent cash burn can increase reliance on external funding, constrain investment choices, and make the company more vulnerable if weak cash conversion continues over coming quarters.
Higher Financial LeverageThe rise in debt relative to equity marks a clear deterioration from the company’s previously conservative leverage profile. Higher leverage reduces financial flexibility while earnings are weaker, potentially limiting capital allocation options and increasing the consequences of continued operating underperformance.
IVD Medical Holding Limited News
1931 FAQ
What was IVD Medical Holding Limited’s price range in the past 12 months?
IVD Medical Holding Limited lowest stock price was HK$0.40 and its highest was HK$10.25 in the past 12 months.
What is IVD Medical Holding Limited’s market cap?
IVD Medical Holding Limited’s market cap is HK$664.81M.
When is IVD Medical Holding Limited’s upcoming earnings report date?
IVD Medical Holding Limited’s upcoming earnings report date is Mar 12, 2027 which is in 159 days.
How were IVD Medical Holding Limited’s earnings last quarter?
IVD Medical Holding Limited released its earnings results on Aug 30, 2026. The company reported -HK$0.05 earnings per share for the quarter.
Is IVD Medical Holding Limited overvalued?
According to Wall Street analysts IVD Medical Holding Limited’s price is currently Overvalued.
Does IVD Medical Holding Limited pay dividends?
IVD Medical Holding Limited pays a Semiannually dividend of HK$0.062 which represents an annual dividend yield of 17.1%. See more information on IVD Medical Holding Limited dividends here
What is IVD Medical Holding Limited’s EPS estimate?
IVD Medical Holding Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IVD Medical Holding Limited have?
IVD Medical Holding Limited has 1,621,488,000 shares outstanding.
What happened to IVD Medical Holding Limited’s price movement after its last earnings report?
IVD Medical Holding Limited reported an EPS of -HK$0.05 in its last earnings report. Following the earnings report the stock price went down -0.893%.
Which hedge fund is a major shareholder of IVD Medical Holding Limited?
Currently, no hedge funds are holding shares in HK:1931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IVD Medical Holding Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-95.51%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
153.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
IVD Medical Holding Limited
ETHK Labs Inc., formerly IVD Medical Holding Ltd, is an investment holding company that distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers a range of products including IVD analyzers, reagents, and consumables.
Technical Analysis
China Health Group
―
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―